WallStreetZenWallStreetZen

NASDAQ: WHWK
Whitehawk Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Whitehawk Therapeutics earnings were -$15.6M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest WHWK earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$17.7M, down 66.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, WHWK reported annual earnings of -$63.7M, with -3.2% growth.

WHWK past earnings growth

How has WHWK's earnings growth performed historically?

Company
N/A
Industry
59.17%
Market
55.29%
WHWK's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
WHWK's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

WHWK earnings history

Current Revenue
$14.4M
Current Earnings
-$15.6M
Current Profit Margin
-108.6%

WHWK Return on Equity

Current Company
-10.4%
Current Industry
-21.2%
Current Market
35.4%
WHWK's Return on Equity (-10.4%)... subscribe to Premium to read more.
High Return on Equity Performance

WHWK undefined

Current Company
-9.6%
Current Industry
-8.7%
WHWK is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when WHWK announces earnings.

WHWK undefined

Current Company
-9.94%
Current Industry
-3.4%
WHWK has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

WHWK vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
WHWK-$15.30M-$15.62M-99.01%$0.14
FATE-$141.44M-$156.09MN/A-$1.33
ANVS-$24.88M-$24.88MN/A-$1.39
ABOS-$128.99M-$133.35MN/A-$2.22
EXOZ-$8.40M-$8.34MN/A-$1.02
View Top Biotech Stocks

Whitehawk Therapeutics Earnings Reports & History FAQ

What were Whitehawk Therapeutics's earnings last quarter?

Whitehawk Therapeutics (NASDAQ: WHWK) reported Q3 2025 earnings per share (EPS) of -$0.26, up 43.48% year over year. Total WHWK earnings for the quarter were -$17.75 million. In the same quarter last year, Whitehawk Therapeutics's earnings per share (EPS) was -$0.46.

If you're new to stock investing, here's how to buy Whitehawk Therapeutics stock.

Is Whitehawk Therapeutics profitable or losing money?

As of the last Whitehawk Therapeutics earnings report, Whitehawk Therapeutics is currently losing money. Whitehawk Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$15.62 million, a 74.68% decrease year over year.

What was WHWK's earnings growth in the past year?

As of Whitehawk Therapeutics's earnings date in Q4 2025, Whitehawk Therapeutics's earnings has grown year over year. WHWK earnings in the past year totalled -$15.62 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.